Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-060752

EVP and General Counsel sold 310 shares at $81.14 ($25,153)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Parschauer Karah Herdman EVP and General Counsel 2021-10-14 Sale −310 $81.14 $25,153 28,358 D: show line 1 in the form
Open-market sales · 310 sh · avg $81.14 · $25,153
Loading xslF345X03/doc4.xml…